You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Dow
Colorcon
Merck
Medtronic

Last Updated: February 26, 2024

Lgm Pharma Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for LGM PHARMA, and what generic and branded alternatives to LGM PHARMA drugs are available?

LGM PHARMA has thirteen approved drugs.



Summary for Lgm Pharma
US Patents:0
Tradenames:12
Ingredients:12
NDAs:13

Drugs and US Patents for Lgm Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lgm Pharma BUTALBITAL, ASPIRIN AND CAFFEINE aspirin; butalbital; caffeine CAPSULE;ORAL 205230-001 Oct 18, 2021 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Lgm Pharma GLYCOPYRROLATE glycopyrrolate TABLET;ORAL 091522-001 Mar 12, 2012 RX No No ⤷  Try a Trial ⤷  Try a Trial
Lgm Pharma CHENODIOL chenodiol TABLET;ORAL 091019-001 Oct 22, 2009 RX No Yes ⤷  Try a Trial ⤷  Try a Trial
Lgm Pharma NABUMETONE nabumetone TABLET;ORAL 203166-001 Aug 30, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Lgm Pharma NABUMETONE nabumetone TABLET;ORAL 203166-002 Aug 30, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Lgm Pharma BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 209587-001 Oct 31, 2018 AA RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Merck
McKinsey
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.